Sanghuangporus sanghuang (SS) is a mushroom that belongs to the genus Sanghuangporus and it is commonly called "Sangwhang" in Taiwan. It is popular in oriental countries and has been traditionally used as food and medicine. The mystery surrounding it was solved in 2012, when it was discovered. However, existing research has not extensively investigated the anti-inflammatory effect of sanghuang that grows on Morus trees. The aim of this study is to investigate the protective effects and underlying mechanism of SS on inflammation by lipopolysaccharide (LPS) induced in vitro and in vivo. Results showed that SS treatment markedly attenuated LPS-induced lung edema, by elevation of the levels of interleukin (IL)-1b, tumor necrosis factor (TNF)-a and IL-6 in bronchoalveolar lavage fluid (BALF) accompanied by a remarkable improvement of lung histopathological symptoms. Additionally, western blotting results suggest that anti-inflammatory effects of SS against the LPS-induced ALI may be due to its ability to inhibit the PI3K/Akt/mTOR/IKK, NF-kB and MAPK signaling pathways. Notably, our results suggest that SS suppresses LPS-induced ROS by inducing Nrf2 activation and HO-1, thioredoxin-1 expression in the lung tissues. Moreover, these findings suggest a potential application of SS in pulmonary inflammatory disease therapy.
Introduction
The respiratory system is oen exposed to dust and airborne pathogens, and respiratory epithelial tissue clears foreign pathogens through activation of the immune response, thereby maintaining health. 1 However, a common cause of respiratory tract inammation is infection caused by Gram-negative bacteria, which contain endotoxins in their cell membrane; endotoxins irritate the respiratory tract, thereby triggering an immune response. 2 This attracts neutrophils and macrophages that accumulate in lung tissue as a means to clear pathogens. However, leukocytes take a long time to inltrate the lung tissue, which not only delays the time taken to relieve the inammatory response, but also causes increasingly serious damage to the lung tissue.
1,2 Acute lung inammation results in lung damage, referred to as acute lung injury (ALI). ALI is a common but serious lung disease that in severe cases, can easily lead to acute respiratory distress syndrome (ARDS) and sepsis, both of which have high mortality rates. 2, 3 Thus far, no effective treatment for ALI is available. Lipopolysaccharide (LPS), a component of the cell membrane of Gram-negative bacteria, is a common environmental endotoxin. Toll-like receptor 4 (TLR4) is the receptor for LPS. 4 When LPS binds to TLR4 expressed in respiratory epithelial cells, the downstream signaling pathways nuclear factor-kB (NF-kB) and mitogen-activated protein kinase (MAPK) are activated by myeloid differentiation factor 88 (MyD88), causing alveolar macrophages to secrete large amounts of pro-inammatory cytokines. 5 These cytokines cause neutrophils in the peripheral blood vessels to migrate and gather in the alveolar and interstitial space, where large amounts of free radicals and reactive oxygen species (ROS) are released as a means to kill the foreign pathogens. 6 However, this release can also damage the surrounding alveolar epithelium, resulting in pulmonary interstitial edema, disruption of the alveolar epithelial barrier, and leakage of large amounts of protein into the alveoli, consequently resulting in serious lung damage.
4-7
Phosphatidylinositol 3-kinase (PI3K) and its downstream target protein kinase B (also known as Akt), Akt can inuence cell survival and are relevant to lipopolysaccharide (LPS)-induced signal transduction. Akt can regulate nuclear factor (NF)-kB activation caused by LPS. By promoting IkB kinase (IKK) for NF-kB phosphorylation, Akt can increase the transcription ability of NF-kB. 8 Moreover; Akt can regulate the activity of mechanistic target of rapamycin (mTOR). A recent study showed that aer phosphorylation by Akt, mTOR can bind to and phosphorylate IKK in order to promote NF-kB activation.
8,9
Inhibition of mTOR can reduce LPS-induced production of proinammatory cytokines and NF-kB phosphorylation. 9 This indicates that the route for PI3K/Akt/mTOR/IKK signal transduction has an essential impact on NF-kB activation.
8-10
Many studies have reported numerous inammatory substances and excessive oxidative stress in ALI patients. 11 To determine an effective treatment for ALI, one must rst identify a medication that can inhibit inammation in the lungs and suppress excess oxidative stress in the body. 12 The use of Sanghuangporus sanghuang (abbreviated in this article as SS or sanghuang), a valuable medicinal fungus, has been widespread in China, Japan, and Korea for more than a millennium. The mystery surrounding it was solved in 2012, when it was discovered by Wu et al. 13, 14 Being extremely rare, genuine sanghuang is distributed throughout mainland China, Japan, South Korea, and Taiwan; and it only grows on mulberry (Morus) trees in the wild.
A recent study reported that sanghuang has moderate pharmacological activity: it enhances immunity, antitumor, 15, 16 antiinammatory, [16] [17] [18] antioxidant activity; [16] [17] [18] and hepatoprotective effects; 19 among others. According to a research report, the active compounds in the sanghuang fruiting body include polysaccharides, triterpenoids, pyran and furan ketones, and polyphenolic compounds. 20 However, existing research has not extensively investigated the anti-inammatory effect of sanghuang that grows on Morus trees.
Therefore, the aim of this study was to investigate whether sanghuang that grows on Morus trees has an anti-inammatory ability, through both in vitro and in vivo experiments: one using endotoxin-induced macrophage cells, and the other using an endotoxin-induced ALI mouse model to assess the antiinammatory capacity of sanghuang and investigate its possible mechanism.
Materials and methods

Source of material
This study used basidiocarps from sanghuang varieties: S. sanghuang grown on Morus. Dr Sheng-hua Wu of the Department of Botany of the National Museum of Natural Science, Taiwan kindly identied and supplied varieties.
Sample extraction
Dried sanghuang powders were immersed in and extracted with 70% ethanol for ve days, followed by ltration. Filtrates were concentrated under reduced pressure to remove ethanol. This step was repeated four times to obtain the extracts, which were then stored for subsequent analysis.
Cell culture
A murine macrophage cell line RAW264. Take half of each group for the inammation protein analysis, slicing, and edema and the rest of mice use for BALF analysis. Mice were intratracheally instilled with 5 mg kg À1 LPS in 50 mL sterile saline or sterile saline alone (control group). In brief, mice were anesthetized with mixed reagent of 10 mL g À1 i.p. urethane (0.6 g mL À1 ) and chloral hydrate (0.4 g mL À1 ), followed by Dex (10 mg kg À1 ) or lobeline intraperitoneal injection with individual dose. Six hours later, the mice received sacrice and bronchoalveolar lavage uid (BALF) and lung tissues were collected.
Bronchoalveolar lavage uid (BALF), total cell count and protein analysis
Six hours later, mice were exsanguinated aer anesthesia. According to the previous report, BALF was collected by the upper part of the trachea, by douche three times with 500 mL PBS (pH 7.2). The uid recovery rate was more than 90%. Lavage sample from each mouse was kept on ice. BALF was centrifuged at 700Âg for 5 min. The sediment cells were resuspended in 2 mL PBS, half of them have used to detect cell counts by cytometer, the rest equally divided into two parts. One has centrifuged again in order to get sediment for extracting proteins with a RIPA solution (radioimmuno-precipitation assay buffer) and centrifuged again to obtain the supernatant in order to detect total protein content by Bradford assay. 
Lung wet/dry weight ratio
The lower lobe of the le lung was blotted dry and weighed before being placed in an oven at 80 C for 48 h to obtain the "dry" weight. The ratio of the wet lung weight to the dry lung weight was calculated to assess tissue edema. The right lungs were used for histopathological examination.
H&E staining
The right lung was harvested and xed in 10% buffered formalin for 24 h, dehydrated, embedded in paraffin before being stained with hematoxylin and eosin (H&E) and observed under light microscopy. PBS and RIPA were added to lung tissue before grinding. The extract was then centrifuged at 12 000Âg for 15 min to obtain the supernatant. Bovine serum albumin (BSA) was used as a protein standard to calculate the equal total cellular protein amounts. Protein samples (50 mg) were resolved by denaturing 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using standard methods, and then were transferred to PVDF membranes (Immobilon, Millipore, Bedford, MA, USA) by electroblotting and blocking with 5% skim milk. The membranes were then incubated with mouse monoclonal anti-iNOS, anti-COX-2, anti-NF-kB (p65), anti-IkB, anti-p-IkB, anti-Nrf2, anti-HO-1, anti-MAPK antibody and antioxidative enzymes (SOD, GPx, Catalase, Trx-1) in TBST at 4 C overnight, washed three times with TBST, and incu- times before being detected for immunoreactive proteins with enhanced chemiluminescence (ECL) using hyperlm and ECL reagent (Thermo, Scientic Hudson, USA). The results of Western blot analysis were quantied by measuring the relative intensity compared to the control by using Kodak Molecular Imaging Soware (Version 4.0.5, Eastman Kodak Company, Rochester, NY) and represented in relative intensities. Antibodies against Nrf2, HO-1, IkB-a, p-IkB-a, NF-kB, P38 and b-actin were obtained from Abcam (Cambridge, UK, USA). Antibodies against iNOS, COX-2, p-ERK1/2, p-JNK, JNK, Trx-1, Keap-1, KAP1, GPX1, CAT, SOD-1, TLR4, AKT and HMGB1 was purchased from Gene Tex (San Antonio, TX, USA). Antibodies against ERK1/2, MPO, IKK, p-IKK and p-mTOR was obtained from Cell Signaling Technology (Danvers, MA, USA). Antibody against p-P38, p-AKT, PI3K was purchased from Millipore (Billerica, MA, USA).
Protein extraction and western blot analysis
Fingerprint analysis by HPLC
The analysis will be performed on a HITACHI HPLC L-5000 system equipped with adegasser, pumps, and a photodiode array detector linked to a PC computer running the soware program HPLC LACHROM. For HPLC analysis, an aliquot (10 mL) is injected into the columns and eluted at 40 C. The analytical column (250 Â 4.6 mm i.d., 5 mm) used is Thermo Hypersil GOLD C 18 (USA), and the detection wavelength. For photodiode array detection, the wavelengths of standard compounds at their respective maximum absorbance wavelength can monitored at the same time. Identication is based on retention times and on-line spectral data in comparison with authentic standards. The mobile phase contained acidied water with acetic acid (2.5%, solvent A) and methanol (solvent B). The gradient program started with 10% solvent B for 0 min, then linearly increased to 20% solvent B for another 5 min. This linear gradient was followed by an isocratic elution until 30 min and reconditioning steps to return to the initial mobile phase condition. The ow rate was 0.8 mL min
À1
, and the injection volumes of standards and samples were 10 mL.
Statistical analysis
Unless otherwise stated, all experiments were performed at least three times independently. Experimental results were presented as the mean AE standard deviation (SD) of three parallel measurements. Statistical evaluation was carried out by one-way analysis of variance (ANOVA) followed by Scheffe's multiple range tests. Statistical signicance was expressed as #p < 0.05, ##p < 0.01 and ###p < 0.001 were compared with sample of control-alone group; *p < 0.05, **p < 0.01, and ***p < 0.001, were compared with LPS-alone group.
Results
Cytotoxicity and NO inhibition
As shown in Fig. 1 , administration of various doses of SS did not affect the viability of murine macrophages, while administration of a nontoxic dose of SS could signicantly reduce the levels of LPS-induced nitric oxide (NO) and proinammatory cytokines in macrophages.
Effects of SS on LPS-induced iNOS, COX-2, NF-kB, MAPK and TLR4/PI3K/Akt/mTOR/IKKb protein expressions in macrophages
Meanwhile, it was also found that SS could signicantly reduce the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), as shown in Fig. 2A . In SSadministered groups, protein expression levels of cytoplasmic NF-kB p65 and inhibitor of IkBa, along with p-IkBa, decreased. As shown in Fig. 2 , LPS-alone group markedly increased the translocation of NF-kB p65 to the nucleus. However, treatment of SS signicantly reduced the nuclear translocation of NF-kB p65. Furthermore, SS signicantly regulated the phosphorylation of intracellular extracellular signal-regulated kinases 1 and 2 (ERK-1/2), c-Jun n-terminal kinase (JNK 1), and p38 proteins. As shown in Fig. 2C , TLR4 and PI3K protein expression was signicantly induced, and Akt and IKKb protein phosphorylation increased in the LPS-induced group as compared with that reported for the control group. Compared with the LPS group, the SS-administered group showed a signicant reduction in the activity of the TLR4/PI3K/Akt/mTOR/IKKb signaling pathway.
Effects of SS on LPS-induced antioxidative enzymes, HO-1, Trx-1/Nrf2 proteins expressions and ROS production in macrophage
In terms of antioxidant enzymes in cells, in SS-administered groups, there was a signicant increase in intracellular protein expression of glutathione peroxidase (GPX), superoxide dismutase (SOD), catalase (CAT), heme oxygenase-1 (HO-1), thioredoxin-1 (Trx-1) and nuclear factor erythroid-2-related factor (Nrf2) in the cytoplasm, as shown in Fig. 3A .
Thus, we investigated whether SS attenuates LPS-stimulated ROS production. As shown in Fig. 3B , SS treatment signicantly reduced LPS-induced ROS production in a dose-dependent manner in RAW 264.7 cells. These ndings suggest that the anti-inammatory effect of SS may be associated with its antioxidant effects in RAW 264.7 cell.
Effects of SS on LPS-mediated lung histopathologic changes
In tissue sections, as shown in Fig. 4 , marked alveolar and interstitial thickening as well as edema with leukocyte inltra-tion was observed in LPS groups. In groups administered SS and DEX prior to LPS induction, alveolar and interstitial edema could be reduced, and leukocyte inltration could be alleviated, as shown in Fig. 4 .
SS attenuates pulmonary edema and reduces cellular counts and proteins in BALF in LPS-induced ALI mice
Comparisons of wet/dry lung weight ratios, cell numbers and protein concentrations in bronchoalveolar lavage uid, and lung myeloperoxidase (MPO) activity are shown in Fig. 5 . Compared with the control group, the LPS-induced group sowed a signicant increase in wet/dry lung weight ratio, cell numbers and protein concentrations in bronchoalveolar lavage uid, and lung MPO activity. As shown in Fig. 5 , a signicant reduction in wet/dry lung tissue weight ratio and MPO activity, as well as cell counts and protein concentrations in bronchoalveolar lavage uid was observed in groups rst administered LPS, as compared with the values reported for the LPSinduced group. , and IL-6 (E) production in LPS-stimulated RAW264.7 cells. Cells were incubated with or without LPS (100 ng mL À1 ) in the presence of various doses (125, 250 and 500 mg mL À1 ) of SS for 24 h. The data were presented as mean AE SD for the three different experiments performed in triplicate. ###p < 0.001 were compared with sample of control-alone group (one-way ANOVA followed by Scheffe's multiple range tests). **p < 0.01, and ***p < 0.001 were compared with LPS-alone group. 
Effect of SS on BALF cytokine levels and iNOS, COX-2 protein expressions in LPS-induced ALI mice
In the body, excessive concentrations of NO and pro-inammatory cytokines play an important role in the pathogenesis of LPS-induced ALI. As shown in Fig. 6 , compared with the control group, the LPSinduced group showed a signicant increase in the concentrations of tumor necrosis factor-alpha (TNF-a), interleukin-1 beta (IL-1b), interleukin-6 (IL-6), and NO in bronchoalveolar lavage uid.
Compared with the LPS group, the SS-administered group exhibited a signicant reduction in concentrations of TNF-a, IL-1b, IL-6, and NO in bronchoalveolar lavage uid. Furthermore, as shown in Fig. 6 , there was a signicant increase in the concentration of interleukin-10 (IL-10) in bronchoalveolar lavage uid in the SS group as compared with the results observed for the LPS group. ) of SS for 24 h. The data were presented as mean AE SD for the three different experiments performed in triplicate. ###p < 0.001 compared with sample of control-alone group (one-way ANOVA followed by Scheffe's multiple range tests). **p < 0.01, and ***p < 0.001 were compared with LPS-alone group. ) of SS for 24 h. Then 10 mM DCFH-DA was added and incubated for 30 min at 37 C. DCF fluorescence by ROS was measured by Synergy HT Microplate Reader (BioTek Instruments). The data were presented as mean AE SD for the three different experiments performed in triplicate. ###p < 0.001 were compared with sample of control group (one-way ANOVA followed by Scheffe's multiple range tests). *p < 0.05, **p < 0.01, and ***p < 0.001 were compared with LPS-alone group. The protein expression of iNOS and COX-2 was analyzed using western blot. As shown in Fig. 7 , iNOS and COX-2 expression signicantly increased in the LPS group as compared with the values reported for the control group whereas in the SS-administered group, there was a signicant reduction in iNOS and COX-2 protein expression levels in lung tissue, as compared with levels in the LPS group.
Effects of SS on NF-kB and MAPK activation in LPS induced ALI mice
In mice with ALI, aer LPS induction, the NF-kB and MAPK pathways were activated. As shown in Fig. 7 , in the LPS-induced group, the expression levels of NF-kB p65 and IkBa in cytoplasm decreased, while p-IkBa expression in cytoplasm increased, showing that LPS induction activated NF-kB p65 to enter the cell nucleus. In the SS-administered group, the expression levels of NF-kB p65 and IkBa in cytoplasm increased, and the expression of p-IkBa in cytoplasm decreased, indicating that SS can reduce NF-kB p65 entry into the cell nucleus, a signicant change as compared with the LPS group. As shown in Fig. 7 , LPS-alone group markedly increased the translocation of NF-kB to the nucleus. However, treatment of SS (500 mg kg À1 ) signicantly reduced the nuclear translocation of NF-kB. In addition, as compared with the LPS group, the SS-administered group had Six hours after LPS injection with or without SS pretreatments, mice were sacrificed and their lungs were lavaged. The right lower lungs were used to assess wet to dry (W/D) ratio of lung. Cells in the BALF were collected and cytospin preparations were made. Total cells and total proteins in BALF were analyzed. Data represents mean AE SD of 6 mice. ###p < 0.001 were compared with sample of control group (oneway ANOVA followed by Scheffe's multiple range tests). *p < 0.05, **p < 0.01, and ***p < 0.001, were compared with LPS-alone group.
a signicant reduction in ERK 1/2, JNK 1/2, and p38 phosphorylation in lung tissue, as shown in Fig. 7 .
Effect of SS on TLR4/PI3K/Akt/mTOR/IKKb pathway activation in LPS induced ALI mice
Furthermore, this study analyzed the expression levels of proteins related to the TLR4/phosphoinositide 3-kinase (PI3K)/ Akt/mTOR/IkB kinase beta (IKKb) signaling pathway. As shown in Fig. 8 , TLR4 and PI3K protein expression was signicantly induced, and Akt, mTOR and IKKb protein phosphorylation increased in the LPS-induced group as compared with that reported for the control group. Compared with the LPS group, the SS-administered group showed a signicant reduction in the activity of the TLR4/PI3K/Akt/mTOR/IKKb signaling pathway.
Effects of SS on LPS-induced antioxidative enzymes and HO-1, Trx-1/Nrf2 protein expressions in ALI mice
As shown in Fig. 8 , compared with the LPS group, the group administered LPS alone showed a signicant reduction in lung tissue expression levels of GPX, SOD, CAT, Trx-1, and Nrf2 proteins in the cytoplasm; however, the signicant increase in lung tissue expression levels of HO-1 and Nrf2 expression in the nucleus. In addition, in the SS-administered group, the
Fig. 6 SS down regulated TNF-a (A), IL-6 (B), IL-1b (C), NO (D), NO (E) and increased IL-10 (F) in BALF.
Six hours after LPS injection with or without SS pre-treatments, mice were sacrificed, their lungs were lavaged and the BALF were collected. TNF-a, IL-6, IL-1b, NO and IL-10 were detected by ELISA. Then 10 mM DCFH-DA was added and incubated for 30 min at 37 C. DCF fluorescence by ROS was measured by Synergy HT Microplate Reader (BioTek Instruments). Data represents mean AE SD of 6 mice. ###p < 0.001 were compared with sample of control group (one-way ANOVA followed by Scheffe's multiple range tests). *p < 0.05, **p < 0.01, and ***p < 0.001, were compared with LPS-alone group. expression of GPX, SOD, CAT, Trx-1, and cytoplasm of Nrf2 in lung tissue signicantly increased as compared with that reported for the LPS group.
Blocking TLR4 with TAK-242 synergistically increases the anti-inammatory potential of SS in RAW 264.7 macrophages
To conrm involvement of the TLR4 signaling pathway in the SS-mediated anti-inammatory potential, we selected TAK-242 (100 ng mL À1 ) inhibit agent, which blocks TLR4-mediated signaling. As shown in Fig. 9 , we found that SS and TAK-242 co-treatment synergistically inhibited LPS-induced production of NO and ROS as well as iNOS, COX-2 and NF-kB p65 expression. Furthermore, the effects of LPS-enhanced TNF-a and IL-1b release were successfully inhibited by blocking TLR4 signaling with TAK-242, and co-treatment of SS with TAK-242 almost completely inhibited the production of those pro-inammatory cytokines to background levels similar to that in the untreated control (Fig. 9) .
Blocking TLR4 with TAK-242 synergistically increases the anti-inammatory potential of SS in ALI mice
In mice with ALI, to determine whether TAK-242 could inhibit TLR4-mediated signaling pathways or not, we analyze TLR4 pathway related protein expression in LPS-exposed mice treatment with TAK-242 (3.0 mg kg À1 ).
As shown in Fig. 10 , the effects of LPS-induction TNF-a, IL1b, IL-6 release were successfully inhibited by blocking TLR4 signaling with TAK-242, and co-treatment of SS with TAK-242 almost completely inhibited the production of those proinammatory cytokines compared with that reported for the untreated control group. However, we found that SS and TAK-242 co-treatment synergistically inhibited LPS-induced production of NO as well as iNOS, COX-2 and NF-kB p65 expression. Furthermore, the administration of 3.0 mg kg À1 of TAK-242, and co-treatment of SS with TAK-242 almost markedly reduced the cell numbers, protein concentrations and MPO level in the BALF, suggesting that TAK-242 and SS might inhibit the degranulation of neutrophils (Fig. 10) . Fig. 7 Effects of SS on LPS-induced iNOs, COX-2, IkB-a, and NF-kB protein expression in lung (A), MAPK phosphorylation (B) expression in ALI mice. Mice were pretreated with different concentrations of SS for 1 h and stimulated with LPS. The Western blotting by using an antibody specific were used for the detection of iNOs, COX-2, IkB-a phosphorylated, NF-kB nuclear and cytosol, and total forms of three MAPK molecules, ERK, p38, and JNK. Data represents mean AE SD of 6 mice. ###p < 0.001 were compared with sample of control group (one-way ANOVA followed by Scheffe's multiple range tests). **p < 0.01, and ***p < 0.001, were compared with LPS-alone group.
HPLC prole of SS
The major components of SS were analyzed by HPLC (Fig. 10A ).
As compared with standard reference compounds, four compounds were identied and determined: (1) protocatechuic acid: (2) protocatechualdehyde; (3) caffeic acid; (4) DBL (3,4-dihydroxybenzalacetone).
Discussion
The local protective response to tissue damage or microbial invasion is inammation; it leads to capillary dilation, increased permeability, and leukocyte migration to the inamed area, wherein leukocytes phagocytose or dilute pathogens. [21] [22] [23] However, an excessive or continuous inammatory response is closely related to the development of numerous diseases, such as acute lung injury (ALI), asthma, inammatory bowel disease, sepsis, or cancer. [24] [25] [26] In the process of development of these diseases, the inammatory response plays a critical role. Previous studies have found that at the site of inammation, macrophages release large amounts of proinammatory factors. If the production of proinammatory substances can be inhibited, the inammatory response can be alleviated, leading to the treatment of the disease.
27,28
According to the results of cell experiments performed in this study, at concentrations that do not affect murine macrophage cell viability, SS can signicantly regulate not only the expression of factors related to the inammatory response but also the production of proinammatory substances. SS administration can also improve the inammatory nature of macrophages by inhibiting the activation of the NF-kB signaling pathway and MAPK phosphorylation.
In addition, many studies have indicated that inammation of the lungs owing to infection is mostly caused by the release of endotoxins by Gram-negative bacteria, which are an important Fig. 8 Effects of SS on LPS-induced TLR4, PI3K, AKT, mTOR, and IKK protein expression and anti-oxidative enzymes, HO-1/Nrf2 protein expression in lung in ALI mice. Mice were pretreated with different concentrations of SS for 1 h and stimulated with LPS. The Western blotting by using an antibody specific were used for the detection of TLR4, PI3K, AKT, mTOR, and IKK protein expression. The Western blotting by using an antibody specific were used for the detection of HO-1/Nrf2, total forms of antioxidative enzymes, catalase, GPx1, and SOD-1Data represents mean AE SD of 6 mice. #p < 0.05, ###p < 0.001 were compared with sample of control group (one-way ANOVA followed by Scheffe's multiple range tests). **p < 0.01, and ***p < 0.001, were compared with LPS-alone group. ) in TAK-242 at 100 ng mL À1 or SS at 500 mg mL À1 for 24 h. The data were presented as mean AE SD for the three different experiments performed in triplicate. ###p < 0.001 compared with sample of control-alone group (one-way ANOVA followed by Scheffe's multiple range tests). ***p < 0.001 were compared with LPS-alone group. pathogenic factor. 25 Therefore, ALI animal models induced by intratracheal instillation of endotoxins are oen adopted to investigate the pathogenic mechanism underlying ALI and its effective treatments.
These models are established by intratracheal instillation of LPS in mice, which induces changes in the pulmonary microvascular epithelium and permeability of epithelial cells that lead to pulmonary edema. Meanwhile, this instillation drives large numbers of leukocytes to gather in the inamed interstitial tissues. Furthermore, large amounts of neutrophils, as well as signicantly increased MPO activity can be found in microvessels in lung biopsy tissue sections. 26 This study reported similar ndings, indicating that neutrophils play an important role in the process of inammation caused by endotoxins. This is mainly because activated neutrophils can release large amounts of free radicals and proteases that promote pulmonary edema and microvascular permeability.
In this study, 6 hours aer intratracheal instillation of LPS, a signicant increase in wet/dry lung tissue weight ratios and protein contents of bronchoalveolar lavage uid was observed. This shows that since the cytoskeleton may contract when epithelial cells are damaged, changes occur in the space within epithelial cells, leading to an increase in vascular permeability, and this subsequent increase in vascular permeability allows moisture in the blood to enter the interstitial space in the lungs more easily, resulting in formation of pulmonary edema. [26] [27] [28] [29] In cases of more severe damage to epithelial cells, the accompanying changes in vascular permeability allow large protein molecules to enter the interstitial space in the lungs, causing an increase in the concentration of proteins in bronchial washings.
25
Administration of 125, 250, and 500 mg kg À1 SS over 5 consecutive days following LPS induction decreased the wet/dry lung tissue weight ratio, as well as the total cell numbers and protein concentrations in bronchial washings. These results suggests that the reduction may be due to the ability of SS to reduce damage to pulmonary microvessels and alveolar cells by reducing the release of proinammatory substances and free radicals, thereby changing the permeability of pulmonary microvessels. Additionally, prior administration of SS can reduce not only the accumulation of leukocytes in bronchial washings but also MPO activity in lung tissues. Further observation of lung tissue sections showed that when murine lung tissue was damaged, neutrophil accumulation and injury decreased in the lung tissues of the SSadministered group. Therefore, it was speculated that sanghuang extract can reduce the production of proinammatory substances by reducing the inltration of neutrophils, thereby improving the damage caused to alveolar epithelial cells and pulmonary microvascular endothelial cells.
Furthermore, stimulation of lung tissues by endotoxins promoted the activity of neutrophils and macrophages in pulmonary tissues and triggered the release of a large number of proinammatory cytokines, such as TNF-a, IL-1b, and IL-6 as well as free radicals that can continue the inammatory process, leading to more serious tissue inammation and even apoptosis. [29] [30] [31] [32] Based on the results of this study, a signicant increase in TNF-a, IL-1b, and IL-6 concentrations in bronchoalveolar lavage uid was observed aer LPS induction. This shows that when tissues are subjected to foreign infection, inammatory cells are driven to release large amounts of inammatory substances, which indirectly activate the immune system, leading to an inammatory response as a means to clear the foreign infectious substances.
32,33
In the present study, prior administration of SS improved damage to the lung tissue by reducing the production of TNF-a, IL-1b, and IL-6 in bronchoalveolar lavage uid caused by LPS induction, and increasing the concentration of IL-10 and cytokine synthesis inhibitory factor.
As shown in previous studies, NO is released in large amounts in the LPS-induced ALI model. Furthermore, when the inammatory response is stimulated, neutrophils, macrophages, endothelial and epithelial cells activate iNOS and produce large amounts of NO, which further attacks pulmonary microvascular endothelial cells, causing damage to lung tissues. 31, 32 The results of this study show that prior administration of SS can improve damage to lung tissues that is caused by LPS-induced ALI, by reducing the expression of iNOS and COX-2 in the lung tissues.
When LPS binds to TLR4 expressed by cells, the physiological role of cells is altered owing to activation of signaling pathways related to either cell survival or the inammatory response. Previous studies have shown that LPS causes phosphorylation of Akt through PI3K, and phosphorylated Akt promotes activation of the NF-kB and MAPK downstream signaling pathways through IKK, which regulates the release of proinammatory cytokines by the respiratory epithelium and maintains cell viability. 9, 27, [29] [30] [31] [32] [33] [34] Recent studies have implicated mTOR in the regulation of cell survival and immune responses. mTOR is downstream of PI3K/Akt during signal transduction. Akt can phosphorylate mTOR, which interacts with IKK, leading to NF-kB activation. mTOR plays an important role in LPSinduced inammatory responses. Inhibition of mTOR can reduce NF-kB phosphorylation in neutrophil leukocytes and pro-inammatory cytokine expression. 8, 10, [34] [35] [36] According to the results of this study, prior administration of SS can reduce activation of the signaling pathways triggered by LPS induction by regulating TLR4/PI3K/Akt/mTOR and IKK protein expression levels. This inhibits NF-kB from actively entering the nucleus and reduces phosphorylation of the MAPK pathway, thus not only reducing the release of proinammatory cytokines and inammatory substances, but also improving damage to lung tissues.
TAK-242, is a selective TLR4 signal transduction inhibitor. According to the relevant research has been shown TAK-242 can reduce production of multiple inammatory mediators such as nitric oxide (NO), tumor necrosis factor (TNF)-a, interleukin (IL)-1, IL-6.
37-39 Moreover, TAK-242 also effectively attenuated the neutrophil activation and accumulation in the lungs, as well as inhibited the DNA binding activation of NF-kB induced by LPS challenge. 40 Therefore, TAK-242 may be a potential inhibitor of adhesion molecules and inammatory mediators. In this study, we selected TAK-242 inhibitors as evidence that SS could regulate LPS-induced TLR4 pathway-related protein expression in vitro and in vivo.
41-46
In addition, combined pretreatment of SS with TAK-242, synergistically attenuated the release of NO, as well as expression of iNOS, COX-2 and NF-kB p65 protein, in vitro and in vivo. In accordance with these results, co-treatment also reduced the production and expression of ROS, TNF-a, IL-6, IL-1b compared to those in the SS or TAK-242 alone treated groups in LPStreated RAW 264.7 macrophages. However, we also found the same results in LPS-induced acute lung injury in mice. Additionally, prior administration of SS and TKA-242 co-treatment can reduce not only the accumulation of leukocytes in bronchial washings but also MPO activity in lung tissues.
According to our results show that SS may inhibit the initiation of intracellular inammatory signaling cascades by attenuating the binding of LPS to TLR4 on macrophages, which is a pivotal upstream signal for NF-kB p65 activation. Therefore, the antagonistic function of SS against TLR4 may be responsible for the anti-inammatory effects of SS in LPS-stimulated RAW 264.7 macrophages or LPS-induced ALI mice.
In the LPS-induced ALI mouse model, large amounts of ROS were produced, mainly because aer neutrophils were activated by LPS, large amounts of surplus oxides, hydrogen peroxide, and reactive oxygen species were released as a means to kill or remove foreign pathogens. However, if excess ROS is produced, there is no way for the body's antioxidant system to remove them in a timely manner, causing the inamed tissue to be aggravated and the situation to be exacerbated. 10, 11, 13, 47 Based on the results of this study, prior administration of SS can reduce the production of ROS that is caused by LPS-induced ALI in tissues. It was speculated that the possible signaling pathway might involve the regulation of levels of protein phosphorylation related to the MAPK signaling pathway, and collaboration with the body's antioxidant enzymes, such as SOD, CAT, GPX, which remove large amounts of ROS from the body, thus alleviating damage caused to tissues.
In addition, HO-1 expression can regulate the cellular inammatory response by, such as, regulating the cellular inammatory response induced by TNF-a and reducing cellinduced cytokine production. 48 Presently, most studies also suggest that when cells are stimulated by external factors, the cellular protective mechanism is initiated and HO-1 expression is induced to resist the attacks by foreign bodies.
The lung is the organ with the highest oxygen content and is susceptible to damage by active oxygen. Redox equilibrium in cells is essential for sustaining the physiological functions of the lung, as well as regulating intracellular and intercellular chemical reactions and signal transductions. Thioredoxin-1 (Trx-1), a signicant redox molecule, plays an important role in antioxidative activities and promoting interconversions between protein disulde bonds and thiols. 49 In recent decades, the effects of Trx-1 in lung diseases have been increasingly recognized. Trx-1 is extensively expressed in various lung cells and regulates intracellular oxidative stress and inammatory responses.
50 Trx-1 can be regarded as an anti-inammatory agent and antioxidant. Furthermore, Nrf2 is overexpressed in detoxifying organs, such as the liver and kidneys, as well as organs that are exposed to the external environment, such as the skin, lungs, and intestinal tract. However, when cells are subjected to a variety of stimuli, the Nrf2 protein binds to the antioxidant response agent (ARE), and participates in the regulation of expression of related antioxidant enzymes, such as HO-1 and Trx-1, to remove oxidative stress. 22, 26, 47, 50 Based on the results of this study, SS contains many polyphenolic compounds, which bear OH groups in their structure and exhibit free radical scavenging ability. Thus, it plays a synergistic role with antioxidant enzymes in eliminating LPS-induced ROS in tissues and therefore, alleviating lung tissue injury. A summary of the results presented in this paper suggests that in LPS-induced ALI, prior administration of SS can trigger related protection mechanism of LPS-induced ALI, as shown in Fig. 11B .
Conclusions
In conclusion, according to the results of this study, sanghuang has a moderate anti-inammatory activity. Both in vitro and in vivo tests showed that sanghuang can regulate TLR4/PI3K/Akt/ mTOR and IKK protein expression levels, inhibit NF-kB from actively entering the nucleus, and reduce phosphorylation of the MAPK pathway, thus reducing the cellular release of proinammatory cytokines and inammatory substances, and alleviating damage to lung tissues. In addition, SS can also coantioxidant enzymes (HO-1 and Trx-1) inhibit cell inamma-tion, and removing large amounts of ROS to improve damage to lung tissues. Sanghuang has considerable potential in the treatment or prevention of inammatory diseases, such as ALI.
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